Evergreen Therapeutics, Inc.

This study tests an experimental pill (EG-301) added to standard AREDS2 supplements in 90 people with dry age-related macular degeneration (AMD) and geographic atrophy. The goal is to see if the drug can slow vision loss and reduce damage to the retina over 6 months. Participants…

This study tests whether adding a drug called EG-007 to the standard combination of lenvatinib and pembrolizumab is safe for people with advanced or recurrent endometrial cancer. About 28 adults whose cancer has returned after chemotherapy will take part. The main goal is to chec…